Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews

BACKGROUND: Transcatheter aortic valve replacement (TAVR) was initially introduced to treat patients with aortic valve stenosis (AS) at high-risk for surgical aortic valve replacement (SAVR). Today, there is ample evidence supporting TAVR in high-risk groups. However, in recent years TAVR has been e...

Descripción completa

Detalles Bibliográficos
Autores principales: Mc Morrow, Roisin, Kriza, Christine, Urbán, Patricia, Amenta, Valeria, Amaro, Juan Antonio Blasco, Panidis, Dimitris, Chassaigne, Hubert, Griesinger, Claudius Benedict
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322533/
https://www.ncbi.nlm.nih.gov/pubmed/32434749
http://dx.doi.org/10.1016/j.ijcard.2020.04.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322533/
https://www.ncbi.nlm.nih.gov/pubmed/32434749
http://dx.doi.org/10.1016/j.ijcard.2020.04.022

Ejemplares similares